admin – Immutek Jsc

New combination immunotherapy plus ART expand innate cells critical to controlling HIV

Yerkes National Primate Research Center researchers in collaboration with Institut Pasteur have determined a combination immunotherapy of Interleukin-21 (IL-21) and interferon alpha (IFNα) when added to antiviral therapy (ART) is effective in generating highly functional natural killer (NK) cells that can help control and reduce simian immunodeficiency virus (SIV) in animal models. This finding, published online today in Nature Communications, is key for developing additional treatment options to control HIV/AIDS, which impacts 38 million people worldwide. ART is the current leading [...]

Chính Sách Bảo Mật Thông Tin

1.Mục đích và phạm vi thu thập thông tin Việc thu thập dữ liệu chủ yếu trên website immutek.com.vn bao gồm: email, điện thoại, địa chỉ khách hàng,..Đây là các thông tin immutek.com.vn cần khách hàng cung cấp bắt buộc khi đăng ký sử dụng dịch vụ và immutek.com.vn liên hệ xác nhận khi khách hàng đăng ký sử dụng dịch vụ tại immutek.com.vn nhằm đảm bảo quyền lợi cho cho người tiêu dùng. Khách hàng sẽ tự chịu trách nhiệm [...]

Chính sách xử lý khiếu nại

– Tiếp nhận mọi khiếu nại của khách hàng liên quan đến việc sử dụng dịch vụ của công ty. – Thời gian giải quyết khiếu nại trong thời hạn tối đa là 03 (ba) ngày làm việc kể từ khi nhận được khiếu nại của của khách hàng. Trong trường hợp bất khả kháng 2 bên sẽ tự thương lượng.

Chính sách thanh toán

Có 2 hình thức thanh toán, khách hàng có thể lựa chọn hình thức thuận tiện và phù hợp với mình nhất: Cách 1: Thanh toán tiền mặt trực tiếp địa chỉ của chúng tôi Cách 2: Chuyển khoản trước. Quý khách chuyển khoản trước, sau đó đặt lịch xét nghiệm chúng tôi sẽ liên hệ lại và báo lịch với quý khách Thông tin tài khoản Chủ tài khoản: CTCP Y SINH IMMUTEK Số tài khoản: 114002655318 Tên ngân hàng: NGÂN HÀNG THƯƠNG MẠI [...]

Now proven against coronavirus, mRNA can do so much more

(CNN)When the final Phase 3 data came out last November showing the mRNA vaccines made by Pfizer/BioNTech and Moderna were more than 90% effective, Dr. Anthony Fauci had no words. He texted smiley face emojis to a journalist seeking his reaction. This astonishing efficacy has held up in real-world studies in the US, Israel and elsewhere. The mRNA technology — developed for its speed and flexibility as opposed to expectations it would provide strong protection against an infectious disease — has [...]

‘Natural killer’ cells found to be a key determinant of severe COVID-19 in patients

Findings hoped to lead to new biomarker to identify patients at higher risk. November 30, 2020 By Ross Neitz An impaired count of natural killer (NK) immune cells and reduced ability to destroy infected cells are key characteristics of severe COVID-19 infection, according to newly published research in the journal Blood Advances. A team of researchers at the University of Alberta and University of Calgary followed 12 patients with severe COVID-19 symptoms at hospitals in Edmonton. They found that the patients had [...]

Immunity after COVID-19 illness may last at least 1 year

By Ernie Mundell Long-term data from northern Italy—an area hit hard during the early days of the pandemic—suggests that reinfection after recovery from COVID-19 infection is very rare, and immunity in former patients could be long-lasting. “Natural immunity to SARS-CoV-2 appears to confer a protective effect for at least a year, which is similar to the protection reported in recent vaccine studies,” concluded a team led by Dr. Nicola Mumoli, of Fornaroli Hospital in Magenta, Italy. The findings, which are based on [...]

FDA clears IND application for CAR-natural killer cell therapy to treat B-cell malignancies

The FDA cleared an investigational new drug application for NKX019, a chimeric antigen receptor-natural killer cell therapy for patients with relapsed or refractory B-cell malignancies, according to the agent’s manufacturer. NKX019 (Nkarta) is an allogeneic, gene-edited CAR-natural killer (NK) cell therapy that targets the CD19 protein on the surface of cancer cells. Source: Adobe Stock. The therapy — derived from the peripheral blood of healthy donors — includes Nkarta’s propriety membrane-bound interleukin-15 activation cytokine to promote NK cell growth and enhanced CAR-NK cell persistence. The [...]

Allogeneic Natural Killer Cells Engineered to Beat Cancer

POWER OF NATURAL KILLER CELLS Cell therapy, a new approach that uses immune cells to attack tumors, has emerged as one of the most promising breakthroughs in cancer treatment. First generation approaches have focused on T-cells, which have shown great promise in hematologic malignancies but are plagued with unwanted side effects and, to date, have not shown similar activity in solid tumors. Nkarta was founded to address these limitations through the application of next generation technologies. NK cells are the body’s first [...]

Natural killer cells lull tumours into dormancy

Natural killer cells can drive spreading cancer cells to enter a state of dormancy. That finding, together with the discovery of a pathway that hinders this antitumour function, could spur the development of new treatments. Noella Lopes & Eric Vivier Efforts to treat tumours that have spread from their initial site in the body to grow elsewhere are often unsuccessful. Such tumours, called metastases, are the main cause of cancer-related deaths, so finding a way to control them is crucial to [...]

Author - admin